Compile Data Set for Download or QSAR
Report error Found 91 Enz. Inhib. hit(s) with all data for entry = 11914
TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660570(US20240092802, Compound 83)
Affinity DataEC50:  1.81nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660529(US20240092802, Compound 41)
Affinity DataEC50:  2.04nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM21015([tyrosyl-3,5-3H(N)]-D-Ala2-Mephe4-glyol5-enkephali...)
Affinity DataEC50:  2.07nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660528(US20240092802, Compound 40)
Affinity DataEC50:  5.53nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM21015([tyrosyl-3,5-3H(N)]-D-Ala2-Mephe4-glyol5-enkephali...)
Affinity DataEC50:  6.98nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660515(US20240092802, Compound 25)
Affinity DataEC50:  8.59nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660536(US20240092802, Compound 48)
Affinity DataEC50:  15.2nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660571(US20240092802, Compound 84)
Affinity DataEC50:  40nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660541(US20240092802, Compound 53)
Affinity DataEC50:  74.1nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660569(US20240092802, Compound 82)
Affinity DataEC50:  122nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660537(US20240092802, Compound 49)
Affinity DataEC50:  137nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660563(US20240092802, Compound 76)
Affinity DataEC50:  145nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660572(US20240092802, Compound tianeptine)
Affinity DataEC50:  194nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660558(US20240092802, Compound 71)
Affinity DataEC50:  222nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660513(US20240092802, Compound 23)
Affinity DataEC50:  264nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660521(US20240092802, Compound 32)
Affinity DataEC50:  563nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660568(US20240092802, Compound 81)
Affinity DataEC50:  573nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660572(US20240092802, Compound tianeptine)
Affinity DataEC50:  641nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660523(US20240092802, Compound 34)
Affinity DataEC50:  657nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660526(US20240092802, Compound 37)
Affinity DataEC50:  893nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660513(US20240092802, Compound 23)
Affinity DataEC50:  1.20E+3nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660508(US20240092802, Compound 18)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660508(US20240092802, Compound 18)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660509(US20240092802, Compound 19)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660509(US20240092802, Compound 19)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660506(US20240092802, Compound 16)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660505(US20240092802, Compound 15)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660507(US20240092802, Compound 17)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660507(US20240092802, Compound 17)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660512(US20240092802, Compound 22)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660512(US20240092802, Compound 22)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660510(US20240092802, Compound 20)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660510(US20240092802, Compound 20)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660511(US20240092802, Compound 21)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660511(US20240092802, Compound 21)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660498(US20240092802, Compound 7)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660497(US20240092802, Compound 6)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660502(US20240092802, Compound 11)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660501(US20240092802, Compound 10)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660504(US20240092802, Compound 14)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660503(US20240092802, Compound 13)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660499(US20240092802, Compound 8)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660499(US20240092802, Compound 8)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660500(US20240092802, Compound 9)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660500(US20240092802, Compound 9)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660533(US20240092802, Compound 45)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660533(US20240092802, Compound 45)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660534(US20240092802, Compound 46)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660530(US20240092802, Compound 42)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660532(US20240092802, Compound 44)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

Displayed 1 to 50 (of 91 total ) | Next | Last >>
Jump to: